Synlogic (SYBX) - Company Revenue

Synlogic, Inc. (SYBX) develops synthetic biologics to combat metabolic disorders, leveraging partnerships to ensure a stable cash flow. The company's commercial revenue, where the metric value is 0.00, links financial stability to achievements in bacterial modification and therapy commercialization. The implementation of robotic laboratories, which provide precision dosing and automated data validation, is accelerating these processes.

SYBX Synlogic, Inc.: Company Revenue in the range 07/04/2022 - 01/24/2026

Analytical breakdowns for Synlogic, Inc.

- price and consensus price forecast:

Stock Price Synlogic Corp|SYBX - Analyst Consensus Forecast

- market capitalization indicators:

Market Value Synlogic, Inc.|SYBX - Total Company Value

- book capitalization information:

Net Asset Value per Share Synlogic|SYBX - Company Book Value|Market Value to Book Value Ratio synlogictx.com|SYBX - Company Total Assets

- company liabilities and liquidity data:

- business earnings and investment ratios data:

SYBX - Company Net Income|Net Profit Forecast Synlogic, Inc.|SYBX - Price to Earnings Ratio|Future Price to Earnings Synlogic Corp|SYBX - Price/Earnings to Growth Ratio|Company Value to EBITDA Synlogic, Inc.|SYBX - Operating profit EBITDA|Net earnings per share for the trailing year Synlogic|SYBX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months synlogictx.com|SYBX - Earnings growth in current year|Expected earnings per share growth for next year Synlogic, Inc.

- sales volume and revenue indicators:

SYBX - Company Sales|Company Future Revenue Synlogic Corp|SYBX - P/S Multiple|Market Cap to Expected Sales Ratio Synlogic, Inc.

Comprehensive company analysis:SYBX synlogictx.com

Synlogic, Inc. (SYBX) aims to commercialize innovative drugs for the therapy of rare diseases. This metric tracks daily revenue inflows, excluding quarterly lags to assess the real-time speed of asset monetization. Investors utilize this indicator as a leading signal of solvency amid a critical liquidity shortage and the risks of development halts. Analyzing the sales volatility of Synlogic, Inc. (SYBX) allows for the timely adjustment of portfolio weights in the event of a business liquidation threat.

Analysis of competing companies